3 ·Filed Oct 14, 2026
Form 3 — initial insider ownership statement
Actionable Insight • Neutral
Monitor future Form 4 filings for any open-market transactions by Shalini Sharp, which could signal conviction. This Form 3 alone provides no actionable trading signal.
Latest settled — T+5d ⚠ clustered
IAM ▼ -22.42% at T+5d
NEUTRAL call -22.42% · α vs SPY -21.41% · entry $18.91 → $14.67
T+1d
+25.91%
call +25.91% · α +27.02%
$23.81
settled 12d ago
T+5d
-22.42%
call -22.42% · α -21.41%
$14.67
settled 6d ago
T+20d
Pending
in 15d
T+60d
Pending
in 3mo
Price Chart
Loading chart...
Executive Summary
Shalini Sharp filed a Form 3 initial statement of beneficial ownership, reporting 66,556 stock options (right to buy) in Iambic Therapeutics, Inc. This is a routine insider filing for a new Section 16 reporting person with no immediate trading signal.
Key Facts
- Shalini Sharp filed a Form 3 on 2026-10-14 as a new Section 16 reporting person.
- Reports 66,556 stock options exercisable at $8.73, expiring 2035-12-02.
- Options vest 25% on 2026-09-25 and 1/48th monthly thereafter.
- No open-market purchases or sales are reported.
Financial Impact
No financial impact — routine initial ownership disclosure.
Risk Factors
- No material risks identified from this filing.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001377202-26-000010 |
| Document: 0001377202-26-000010-index-headers.html | 0001377202-26-000010 |
| Document: 0001377202-26-000010-index.html | 0001377202-26-000010 |
| Document: 0001377202-26-000010.txt | 0001377202-26-000010 |
11 reports for IAM
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | Insider Buy | $16.01 $15.80 | ▼ −1.31% | ▼ −1.84% | $14.26 (−10.93%) |
Oct 16, 2026 10d ago | 8-K | $16.34 $16.01 | ▼ −2.02% | ▼ −2.35% | $14.26 (−12.73%) |
Oct 15, 2026 11d ago | 424B4 | $23.81 $16.34 | ▼ −31.37% | ▼ −31.80% | $14.26 (−40.11%) |
Oct 15, 2026 11d ago | EFFECT | $18.91 $23.81 | ▲ +25.91% | ▲ +27.02% | $14.26 (−24.59%) |
Oct 14, 2026 12d ago | 3 | $18.91 $23.81 | ▲ +25.91% | ▲ +27.02% | $14.26 (−24.59%) |
Oct 14, 2026 12d ago | 3 | $18.91 $23.81 | ▲ +25.91% | ▲ +27.02% | $14.26 (−24.59%) |
Oct 14, 2026 12d ago | 3 | $18.91 $23.81 | ▲ +25.91% | ▲ +27.02% | $14.26 (−24.59%) |
Oct 14, 2026 12d ago | 3 | $18.91 $23.81 | ▲ +25.91% | ▲ +27.02% | $14.26 (−24.59%) |
Oct 14, 2026 12d ago | 3 | $18.91 $23.81 | ▲ +25.91% | ▲ +27.02% | $14.26 (−24.59%) |
Oct 14, 2026 12d ago | 3 | $18.91 $23.81 | ▲ +25.91% | ▲ +27.02% | $14.26 (−24.59%) |
Showing 10 of 11
US Market Status
Market Closed — Opens Wed (12h 45m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers